Literature DB >> 12466363

Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.

Uberto Pagotto1, Alessandra Gambineri, Valentina Vicennati, Mark L Heiman, Matthias Tschöp, Renato Pasquali.   

Abstract

In addition to its orexigenic properties, ghrelin has been shown to modulate the secretory pattern of pituitary hormones, and it may exert direct effects on peripheral organs such as the gonads and endocrine pancreas. To study possible interactions among ghrelin, glucose homeostasis, and the reproductive system, we investigated 10 obese women with polycystic ovary syndrome (OB-PCOS) in comparison with 10 age- and body mass index-matched obese subjects (OB). Plasma levels of insulin, glucose, androgens, and ghrelin were measured at baseline condition and after 7 months of therapy (hypocaloric diet + metformin or placebo). Plasma ghrelin levels were lower in OB-PCOS than in OB (P < 0.05). A strong negative correlation between ghrelin and androstenedione levels was found in both populations at baseline (OB-PCOS: P < 0.01; OB: P < 0.001) and after therapy (OB-PCOS: P < 0.01; OB: P < 0.05), whereas no correlation was found between ghrelin and other androgens. In both groups, the markers of insulin resistance in fasting and stimulated conditions (glucose/insulin ratio, homeostasis model insulin resistance index, homeostasis model applied to the oral glucose tolerance test) demonstrated decreased insulin sensitivity. However, a negative correlation between plasma ghrelin and all these markers was observed only in the OB-PCOS group (P < 0.05). Accordingly, a negative correlation between ghrelin variation and treatment-induced changes of the glucose/insulin ratio, HOMA-R, and HOMA(OGTT) was observed only in the OB-PCOS group (P < 0.05). In conclusion, OB-PCOS women have lower ghrelin levels than those expected based on the presence of obesity. Only in OB-PCOS, ghrelin negatively correlates with insulin sensitivity. In addition, regardless of the presence of PCOS, a marked negative correlation exists between ghrelin and androstenedione levels, suggestive of an interaction between ghrelin and steroid synthesis or action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466363     DOI: 10.1210/jc.2002-020776

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.

Authors:  Diego Perez-Tilve; Ruben Nogueiras; Federico Mallo; Stephen C Benoit; Matthias Tschoep
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

Authors:  William S Denney; Gabriele E Sonnenberg; Santos Carvajal-Gonzalez; Theresa Tuthill; V Margaret Jackson
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

3.  Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.

Authors:  Margaret C Garin; Samantha F Butts; David B Sarwer; Kelly C Allison; Suneeta Senapati; Anuja Dokras
Journal:  Endocrine       Date:  2016-12-21       Impact factor: 3.633

4.  Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men.

Authors:  A Gambineri; U Pagotto; R De Lasio; M C Meriggiola; A Costantino; L Patton; C Pelusi; G Pelusi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

5.  Imbalance Between Postprandial Ghrelin and Insulin Responses to an Ad Libitum Meal in Obese Women With Polycystic Ovary Syndrome.

Authors:  Camila Cremonezi Japur; Rosa Wanda Diez-Garcia; Fernanda Rodrigues de Oliveira Penaforte; Marcos Felipe Silva de Sá
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

6.  Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.

Authors:  A Gambineri; U Pagotto; M Tschöp; V Vicennati; E Manicardi; A Carcello; M Cacciari; R De Iasio; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

7.  Metabolic and cardiovascular effects of ghrelin.

Authors:  Manfredi Tesauro; Francesca Schinzari; Miriam Caramanti; Renato Lauro; Carmine Cardillo
Journal:  Int J Pept       Date:  2010-03-16

8.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

9.  Ghrelin in diabetes and metabolic syndrome.

Authors:  Leena Pulkkinen; Olavi Ukkola; Marjukka Kolehmainen; Matti Uusitupa
Journal:  Int J Pept       Date:  2010-04-27

10.  Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

Authors:  D Micic; M Sumarac-Dumanovic; A Kendereski; G Cvijovic; S Zoric; D Pejkovic; J Micic; N Milic; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.